Physician profile
Paul D Dayton
NPI 1558333914
$9,408,423.85
in general payments reported to CMS, 2019-2025
14 companies · $1.2M in 2025
The $1.2M reported for 2025 was more than what 99% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $519K · 2020: $763K · 2021: $1.4M · 2022: $1.9M · 2023: $2.1M · 2024: $1.6M · 2025: $1.2M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $4.3M · Consulting Fee: $538K · Travel and Lodging: $57K · Food and Beverage: $8,211 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $4,259,812.61 |
| Consulting Fee | $537,643.75 |
| Travel and Lodging | $57,428.37 |
| Food and Beverage | $8,211.22 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $9,406,734.03 | 2019-2025 | |
| Fusion Orthopedics USA, LLC | $563.60 | 2024 | |
| Stryker Corporation | $484.18 | 2021-2025 | 7 X 23mm Citrelock Implant, Axsos, Citrefix |
| Abbvie INC. | $140.04 | 2022-2024 | |
| Orthofix Medical, INC. | $139.49 | 2021-2023 | Physio-Stim |
| Mimedx Group, INC. | $86.11 | 2025 | |
| Smith+Nephew, INC. | $71.56 | 2019-2024 | Grafix Pl, Stravix Pl, Oasis |
| Depuy Synthes Sales INC. | $61.53 | 2019-2023 | Fibergraft Aeridyan Matrix |
| Integra Lifesciences Corporation | $39.89 | 2022-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Musculoskeletal Transplant Foundation INC. | $30.00 | 2022 | |
| Ethicon US, LLC | $23.73 | 2025 | Stratafix |
| Organogenesis INC. | $18.62 | 2025 | Puraply Wound Matrix |
| Kerecis Limited | $17.40 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Paratek Pharmaceuticals, INC. | $13.67 | 2024 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Dayton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.